A molecular survey of 391 milk samples from farms in northern Algeria detected no DNA from five pathogenic mycobacterial ...

QIAGEN launched QIAmini on September 24, 2026. Qiagen stock costs EUR 39.85 in weekend trading on October 3, 2026 versus EUR ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAmini, a compact automated sample preparation system designed to give research laboratories a time-saving and ...

Qiagen launched QIAmini on September 24, 2026, and Qiagen stock was last at EUR 39.16 on the Frankfurt Stock Exchange on ...

QIAGEN N.V. announced the launch of QIAmini, a compact automated sample preparation system designed to give research laboratories a time-saving and cost-efficient alternative to processing samples by ...

QIAGEN is also introducing the QIAGEN Discovery Platform, which enables the integration of AI with QIAGEN’s biomedical ...

QIAGEN N.V.QGEN is well positioned for growth in the upcoming quarters, supported by continued test menu expansion. Meanwhile, strategic partnerships support assay development and create opportunities ...

RNA fusions offer new drug targets and insights into disease mechanisms, but detecting them is difficult. Workflows that integrate different types of samples and analyses can help.

With the addition of the QIAstat-Dx BCID GN Plus AMR Panel, QIAGEN now offers U.S. laboratories two complementary bloodstream infection panels covering gram-negative bacteria, gram-positive bacteria, ...

Antimicrobial resistance is a major global health threat, with disproportionate impact in regions with limited diagnostic ...

A federal judge agreed with the plaintiffs that the disclosure of their DNA profiles to law enforcement against their wishes was a substantial invasion of their privacy.